Frontlight ResearchEarly access
Trial site
Mersin
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease3 trials
- Stroke3 trials
- IgA nephropathy2 trials
- Multiple sclerosis2 trials
- Chronic kidney disease1 trial
- Familial hypercholesterolaemia1 trial
- Hidradenitis suppurativa1 trial
- Lupus (SLE)1 trial
- Sickle cell disease1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals10 trials
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026